img

Global GLP-1 Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global GLP-1 Drug Market Insights, Forecast to 2034

Global GLP-1 Drug market is expected to reach to US$ 25340 million in 2024, with a positive growth of %, compared with US$ 20430 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, GLP-1 Drug industry is evaluated to reach US$ 99940 million in 2029. The CAGR will be 25.7% during 2024 to 2029.
Globally, GLP-1 Drug key manufacturers include Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, Novo Nordisk, Boehringer Ingelheim, GlaxoSmithKline (GSK), East China Pharmaceutical Co., Ltd. and Gan & Lee Pharmaceuticals, etc. Eli Lilly, AstraZeneca, Sanofi are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of GLP-1 Drug were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole GLP-1 Drug market and estimated to attract more attentions from industry insiders and investors.
GLP-1 Drug can be divided into Short-acting GLP-1 Drug and Long-acting GLP-1 Drug, etc. Short-acting GLP-1 Drug is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
GLP-1 Drug is widely used in various fields, such as Obesity, Type 2 Diabetes (T2DM), Cardiovascular and Cerebrovascular Diseases (CVD) and Non-alcoholic Steatohepatitis (NASH), etc. Obesity provides greatest supports to the GLP-1 Drug industry development. In 2022, global % sales of GLP-1 Drug went into Obesity filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global GLP-1 Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global GLP-1 Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Eli Lilly
AstraZeneca
Sanofi
Pfizer Inc
Novo Nordisk
Boehringer Ingelheim
GlaxoSmithKline (GSK)
East China Pharmaceutical Co., Ltd.
Gan & Lee Pharmaceuticals
Tonghua Dongbao
Shanghai Renhui Biopharmaceutical Co., Ltd.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Segment by Type
Short-acting GLP-1 Drug
Long-acting GLP-1 Drug

Segment by Application


Obesity
Type 2 Diabetes (T2DM)
Cardiovascular and Cerebrovascular Diseases (CVD)
Non-alcoholic Steatohepatitis (NASH)
Alzheimer's Disease (AD)

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ GLP-1 Drug plant distribution, commercial date of GLP-1 Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, GLP-1 Drug introduction, etc. GLP-1 Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of GLP-1 Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 GLP-1 Drug Product Introduction
1.2 Market by Type
1.2.1 Global GLP-1 Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Short-acting GLP-1 Drug
1.2.3 Long-acting GLP-1 Drug
1.3 Market by Application
1.3.1 Global GLP-1 Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Obesity
1.3.3 Type 2 Diabetes (T2DM)
1.3.4 Cardiovascular and Cerebrovascular Diseases (CVD)
1.3.5 Non-alcoholic Steatohepatitis (NASH)
1.3.6 Alzheimer's Disease (AD)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global GLP-1 Drug Sales Estimates and Forecasts 2018-2029
2.2 Global GLP-1 Drug Revenue by Region
2.2.1 Global GLP-1 Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global GLP-1 Drug Revenue by Region (2018-2024)
2.2.3 Global GLP-1 Drug Revenue by Region (2024-2029)
2.2.4 Global GLP-1 Drug Revenue Market Share by Region (2018-2029)
2.3 Global GLP-1 Drug Sales Estimates and Forecasts 2018-2029
2.4 Global GLP-1 Drug Sales by Region
2.4.1 Global GLP-1 Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global GLP-1 Drug Sales by Region (2018-2024)
2.4.3 Global GLP-1 Drug Sales by Region (2024-2029)
2.4.4 Global GLP-1 Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global GLP-1 Drug Sales by Manufacturers
3.1.1 Global GLP-1 Drug Sales by Manufacturers (2018-2024)
3.1.2 Global GLP-1 Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of GLP-1 Drug in 2022
3.2 Global GLP-1 Drug Revenue by Manufacturers
3.2.1 Global GLP-1 Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global GLP-1 Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by GLP-1 Drug Revenue in 2022
3.3 Global Key Players of GLP-1 Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global GLP-1 Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global GLP-1 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of GLP-1 Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of GLP-1 Drug, Product Offered and Application
3.8 Global Key Manufacturers of GLP-1 Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global GLP-1 Drug Sales by Type
4.1.1 Global GLP-1 Drug Historical Sales by Type (2018-2024)
4.1.2 Global GLP-1 Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global GLP-1 Drug Sales Market Share by Type (2018-2029)
4.2 Global GLP-1 Drug Revenue by Type
4.2.1 Global GLP-1 Drug Historical Revenue by Type (2018-2024)
4.2.2 Global GLP-1 Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global GLP-1 Drug Revenue Market Share by Type (2018-2029)
4.3 Global GLP-1 Drug Price by Type
4.3.1 Global GLP-1 Drug Price by Type (2018-2024)
4.3.2 Global GLP-1 Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global GLP-1 Drug Sales by Application
5.1.1 Global GLP-1 Drug Historical Sales by Application (2018-2024)
5.1.2 Global GLP-1 Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global GLP-1 Drug Sales Market Share by Application (2018-2029)
5.2 Global GLP-1 Drug Revenue by Application
5.2.1 Global GLP-1 Drug Historical Revenue by Application (2018-2024)
5.2.2 Global GLP-1 Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global GLP-1 Drug Revenue Market Share by Application (2018-2029)
5.3 Global GLP-1 Drug Price by Application
5.3.1 Global GLP-1 Drug Price by Application (2018-2024)
5.3.2 Global GLP-1 Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada GLP-1 Drug Market Size by Type
6.1.1 US & Canada GLP-1 Drug Sales by Type (2018-2029)
6.1.2 US & Canada GLP-1 Drug Revenue by Type (2018-2029)
6.2 US & Canada GLP-1 Drug Market Size by Application
6.2.1 US & Canada GLP-1 Drug Sales by Application (2018-2029)
6.2.2 US & Canada GLP-1 Drug Revenue by Application (2018-2029)
6.3 US & Canada GLP-1 Drug Market Size by Country
6.3.1 US & Canada GLP-1 Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada GLP-1 Drug Sales by Country (2018-2029)
6.3.3 US & Canada GLP-1 Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe GLP-1 Drug Market Size by Type
7.1.1 Europe GLP-1 Drug Sales by Type (2018-2029)
7.1.2 Europe GLP-1 Drug Revenue by Type (2018-2029)
7.2 Europe GLP-1 Drug Market Size by Application
7.2.1 Europe GLP-1 Drug Sales by Application (2018-2029)
7.2.2 Europe GLP-1 Drug Revenue by Application (2018-2029)
7.3 Europe GLP-1 Drug Market Size by Country
7.3.1 Europe GLP-1 Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe GLP-1 Drug Sales by Country (2018-2029)
7.3.3 Europe GLP-1 Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China GLP-1 Drug Market Size
8.1.1 China GLP-1 Drug Sales (2018-2029)
8.1.2 China GLP-1 Drug Revenue (2018-2029)
8.2 China GLP-1 Drug Market Size by Application
8.2.1 China GLP-1 Drug Sales by Application (2018-2029)
8.2.2 China GLP-1 Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia GLP-1 Drug Market Size by Type
9.1.1 Asia GLP-1 Drug Sales by Type (2018-2029)
9.1.2 Asia GLP-1 Drug Revenue by Type (2018-2029)
9.2 Asia GLP-1 Drug Market Size by Application
9.2.1 Asia GLP-1 Drug Sales by Application (2018-2029)
9.2.2 Asia GLP-1 Drug Revenue by Application (2018-2029)
9.3 Asia GLP-1 Drug Sales by Region
9.3.1 Asia GLP-1 Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia GLP-1 Drug Revenue by Region (2018-2029)
9.3.3 Asia GLP-1 Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America GLP-1 Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America GLP-1 Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America GLP-1 Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America GLP-1 Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America GLP-1 Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America GLP-1 Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America GLP-1 Drug Sales by Country
10.3.1 Middle East, Africa and Latin America GLP-1 Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America GLP-1 Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America GLP-1 Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Overview
11.1.3 Eli Lilly GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Eli Lilly GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Eli Lilly Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AstraZeneca GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sanofi GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Pfizer Inc
11.4.1 Pfizer Inc Company Information
11.4.2 Pfizer Inc Overview
11.4.3 Pfizer Inc GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer Inc GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Inc Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Information
11.5.2 Novo Nordisk Overview
11.5.3 Novo Nordisk GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Novo Nordisk GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novo Nordisk Recent Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Overview
11.6.3 Boehringer Ingelheim GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Boehringer Ingelheim GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Boehringer Ingelheim Recent Developments
11.7 GlaxoSmithKline (GSK)
11.7.1 GlaxoSmithKline (GSK) Company Information
11.7.2 GlaxoSmithKline (GSK) Overview
11.7.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 GlaxoSmithKline (GSK) GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 GlaxoSmithKline (GSK) Recent Developments
11.8 East China Pharmaceutical Co., Ltd.
11.8.1 East China Pharmaceutical Co., Ltd. Company Information
11.8.2 East China Pharmaceutical Co., Ltd. Overview
11.8.3 East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 East China Pharmaceutical Co., Ltd. GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 East China Pharmaceutical Co., Ltd. Recent Developments
11.9 Gan & Lee Pharmaceuticals
11.9.1 Gan & Lee Pharmaceuticals Company Information
11.9.2 Gan & Lee Pharmaceuticals Overview
11.9.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Gan & Lee Pharmaceuticals GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Gan & Lee Pharmaceuticals Recent Developments
11.10 Tonghua Dongbao
11.10.1 Tonghua Dongbao Company Information
11.10.2 Tonghua Dongbao Overview
11.10.3 Tonghua Dongbao GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Tonghua Dongbao GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tonghua Dongbao Recent Developments
11.11 Shanghai Renhui Biopharmaceutical Co., Ltd.
11.11.1 Shanghai Renhui Biopharmaceutical Co., Ltd. Company Information
11.11.2 Shanghai Renhui Biopharmaceutical Co., Ltd. Overview
11.11.3 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Developments
11.12 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
11.12.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
11.12.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Overview
11.12.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 GLP-1 Drug Industry Chain Analysis
12.2 GLP-1 Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 GLP-1 Drug Production Mode & Process
12.4 GLP-1 Drug Sales and Marketing
12.4.1 GLP-1 Drug Sales Channels
12.4.2 GLP-1 Drug Distributors
12.5 GLP-1 Drug Customers
13 Market Dynamics
13.1 GLP-1 Drug Industry Trends
13.2 GLP-1 Drug Market Drivers
13.3 GLP-1 Drug Market Challenges
13.4 GLP-1 Drug Market Restraints
14 Key Findings in The Global GLP-1 Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global GLP-1 Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Short-acting GLP-1 Drug
Table 3. Major Manufacturers of Long-acting GLP-1 Drug
Table 4. Global GLP-1 Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global GLP-1 Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global GLP-1 Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global GLP-1 Drug Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global GLP-1 Drug Revenue Market Share by Region (2018-2024)
Table 9. Global GLP-1 Drug Revenue Market Share by Region (2024-2029)
Table 10. Global GLP-1 Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global GLP-1 Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global GLP-1 Drug Sales by Region (2024-2029) & (K Units)
Table 13. Global GLP-1 Drug Sales Market Share by Region (2018-2024)
Table 14. Global GLP-1 Drug Sales Market Share by Region (2024-2029)
Table 15. Global GLP-1 Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global GLP-1 Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global GLP-1 Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global GLP-1 Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of GLP-1 Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. GLP-1 Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global GLP-1 Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global GLP-1 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Drug as of 2022)
Table 23. Global Key Manufacturers of GLP-1 Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of GLP-1 Drug, Product Offered and Application
Table 25. Global Key Manufacturers of GLP-1 Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global GLP-1 Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global GLP-1 Drug Sales by Type (2024-2029) & (K Units)
Table 29. Global GLP-1 Drug Sales Share by Type (2018-2024)
Table 30. Global GLP-1 Drug Sales Share by Type (2024-2029)
Table 31. Global GLP-1 Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global GLP-1 Drug Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global GLP-1 Drug Revenue Share by Type (2018-2024)
Table 34. Global GLP-1 Drug Revenue Share by Type (2024-2029)
Table 35. GLP-1 Drug Price by Type (2018-2024) & (US$/Unit)
Table 36. Global GLP-1 Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global GLP-1 Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global GLP-1 Drug Sales by Application (2024-2029) & (K Units)
Table 39. Global GLP-1 Drug Sales Share by Application (2018-2024)
Table 40. Global GLP-1 Drug Sales Share by Application (2024-2029)
Table 41. Global GLP-1 Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global GLP-1 Drug Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global GLP-1 Drug Revenue Share by Application (2018-2024)
Table 44. Global GLP-1 Drug Revenue Share by Application (2024-2029)
Table 45. GLP-1 Drug Price by Application (2018-2024) & (US$/Unit)
Table 46. Global GLP-1 Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada GLP-1 Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada GLP-1 Drug Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada GLP-1 Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada GLP-1 Drug Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada GLP-1 Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada GLP-1 Drug Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada GLP-1 Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada GLP-1 Drug Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada GLP-1 Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada GLP-1 Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada GLP-1 Drug Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada GLP-1 Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada GLP-1 Drug Sales by Country (2024-2029) & (K Units)
Table 60. Europe GLP-1 Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe GLP-1 Drug Sales by Type (2024-2029) & (K Units)
Table 62. Europe GLP-1 Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe GLP-1 Drug Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe GLP-1 Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe GLP-1 Drug Sales by Application (2024-2029) & (K Units)
Table 66. Europe GLP-1 Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe GLP-1 Drug Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe GLP-1 Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe GLP-1 Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe GLP-1 Drug Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe GLP-1 Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe GLP-1 Drug Sales by Country (2024-2029) & (K Units)
Table 73. China GLP-1 Drug Sales by Type (2018-2024) & (K Units)
Table 74. China GLP-1 Drug Sales by Type (2024-2029) & (K Units)
Table 75. China GLP-1 Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China GLP-1 Drug Revenue by Type (2024-2029) & (US$ Million)
Table 77. China GLP-1 Drug Sales by Application (2018-2024) & (K Units)
Table 78. China GLP-1 Drug Sales by Application (2024-2029) & (K Units)
Table 79. China GLP-1 Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China GLP-1 Drug Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia GLP-1 Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia GLP-1 Drug Sales by Type (2024-2029) & (K Units)
Table 83. Asia GLP-1 Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia GLP-1 Drug Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia GLP-1 Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia GLP-1 Drug Sales by Application (2024-2029) & (K Units)
Table 87. Asia GLP-1 Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia GLP-1 Drug Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia GLP-1 Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia GLP-1 Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia GLP-1 Drug Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia GLP-1 Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia GLP-1 Drug Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America GLP-1 Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America GLP-1 Drug Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America GLP-1 Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America GLP-1 Drug Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America GLP-1 Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America GLP-1 Drug Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America GLP-1 Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America GLP-1 Drug Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America GLP-1 Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America GLP-1 Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America GLP-1 Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America GLP-1 Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America GLP-1 Drug Sales by Country (2024-2029) & (K Units)
Table 107. Eli Lilly Company Information
Table 108. Eli Lilly Description and Major Businesses
Table 109. Eli Lilly GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Eli Lilly GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Eli Lilly Recent Developments
Table 112. AstraZeneca Company Information
Table 113. AstraZeneca Description and Major Businesses
Table 114. AstraZeneca GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. AstraZeneca GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. AstraZeneca Recent Developments
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Pfizer Inc Company Information
Table 123. Pfizer Inc Description and Major Businesses
Table 124. Pfizer Inc GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Pfizer Inc GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Pfizer Inc Recent Developments
Table 127. Novo Nordisk Company Information
Table 128. Novo Nordisk Description and Major Businesses
Table 129. Novo Nordisk GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Novo Nordisk GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Novo Nordisk Recent Developments
Table 132. Boehringer Ingelheim Company Information
Table 133. Boehringer Ingelheim Description and Major Businesses
Table 134. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Boehringer Ingelheim GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Boehringer Ingelheim Recent Developments
Table 137. GlaxoSmithKline (GSK) Company Information
Table 138. GlaxoSmithKline (GSK) Description and Major Businesses
Table 139. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. GlaxoSmithKline (GSK) GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. GlaxoSmithKline (GSK) Recent Developments
Table 142. East China Pharmaceutical Co., Ltd. Company Information
Table 143. East China Pharmaceutical Co., Ltd. Description and Major Businesses
Table 144. East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. East China Pharmaceutical Co., Ltd. GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. East China Pharmaceutical Co., Ltd. Recent Developments
Table 147. Gan & Lee Pharmaceuticals Company Information
Table 148. Gan & Lee Pharmaceuticals Description and Major Businesses
Table 149. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Gan & Lee Pharmaceuticals GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Gan & Lee Pharmaceuticals Recent Developments
Table 152. Tonghua Dongbao Company Information
Table 153. Tonghua Dongbao Description and Major Businesses
Table 154. Tonghua Dongbao GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Tonghua Dongbao GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Tonghua Dongbao Recent Developments
Table 157. Shanghai Renhui Biopharmaceutical Co., Ltd. Company Information
Table 158. Shanghai Renhui Biopharmaceutical Co., Ltd. Description and Major Businesses
Table 159. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Developments
Table 162. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
Table 163. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 164. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. GLP-1 Drug Distributors List
Table 170. GLP-1 Drug Customers List
Table 171. GLP-1 Drug Market Trends
Table 172. GLP-1 Drug Market Drivers
Table 173. GLP-1 Drug Market Challenges
Table 174. GLP-1 Drug Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. GLP-1 Drug Product Picture
Figure 2. Global GLP-1 Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global GLP-1 Drug Market Share by Type in 2022 & 2029
Figure 4. Short-acting GLP-1 Drug Product Picture
Figure 5. Long-acting GLP-1 Drug Product Picture
Figure 6. Global GLP-1 Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global GLP-1 Drug Market Share by Application in 2022 & 2029
Figure 8. Obesity
Figure 9. Type 2 Diabetes (T2DM)
Figure 10. Cardiovascular and Cerebrovascular Diseases (CVD)
Figure 11. Non-alcoholic Steatohepatitis (NASH)
Figure 12. Alzheimer's Disease (AD)
Figure 13. GLP-1 Drug Report Years Considered
Figure 14. Global GLP-1 Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global GLP-1 Drug Revenue 2018-2029 (US$ Million)
Figure 16. Global GLP-1 Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global GLP-1 Drug Revenue Market Share by Region (2018-2029)
Figure 18. Global GLP-1 Drug Sales 2018-2029 ((K Units)
Figure 19. Global GLP-1 Drug Sales Market Share by Region (2018-2029)
Figure 20. US & Canada GLP-1 Drug Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada GLP-1 Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe GLP-1 Drug Sales YoY (2018-2029) & (K Units)
Figure 23. Europe GLP-1 Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China GLP-1 Drug Sales YoY (2018-2029) & (K Units)
Figure 25. China GLP-1 Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) GLP-1 Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) GLP-1 Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America GLP-1 Drug Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America GLP-1 Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The GLP-1 Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of GLP-1 Drug in the World: Market Share by GLP-1 Drug Revenue in 2022
Figure 32. Global GLP-1 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global GLP-1 Drug Sales Market Share by Type (2018-2029)
Figure 34. Global GLP-1 Drug Revenue Market Share by Type (2018-2029)
Figure 35. Global GLP-1 Drug Sales Market Share by Application (2018-2029)
Figure 36. Global GLP-1 Drug Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada GLP-1 Drug Sales Market Share by Type (2018-2029)
Figure 38. US & Canada GLP-1 Drug Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada GLP-1 Drug Sales Market Share by Application (2018-2029)
Figure 40. US & Canada GLP-1 Drug Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada GLP-1 Drug Revenue Share by Country (2018-2029)
Figure 42. US & Canada GLP-1 Drug Sales Share by Country (2018-2029)
Figure 43. U.S. GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 44. Canada GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 45. Europe GLP-1 Drug Sales Market Share by Type (2018-2029)
Figure 46. Europe GLP-1 Drug Revenue Market Share by Type (2018-2029)
Figure 47. Europe GLP-1 Drug Sales Market Share by Application (2018-2029)
Figure 48. Europe GLP-1 Drug Revenue Market Share by Application (2018-2029)
Figure 49. Europe GLP-1 Drug Revenue Share by Country (2018-2029)
Figure 50. Europe GLP-1 Drug Sales Share by Country (2018-2029)
Figure 51. Germany GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 52. France GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 54. Italy GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 55. Russia GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 56. China GLP-1 Drug Sales Market Share by Type (2018-2029)
Figure 57. China GLP-1 Drug Revenue Market Share by Type (2018-2029)
Figure 58. China GLP-1 Drug Sales Market Share by Application (2018-2029)
Figure 59. China GLP-1 Drug Revenue Market Share by Application (2018-2029)
Figure 60. Asia GLP-1 Drug Sales Market Share by Type (2018-2029)
Figure 61. Asia GLP-1 Drug Revenue Market Share by Type (2018-2029)
Figure 62. Asia GLP-1 Drug Sales Market Share by Application (2018-2029)
Figure 63. Asia GLP-1 Drug Revenue Market Share by Application (2018-2029)
Figure 64. Asia GLP-1 Drug Revenue Share by Region (2018-2029)
Figure 65. Asia GLP-1 Drug Sales Share by Region (2018-2029)
Figure 66. Japan GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 70. India GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America GLP-1 Drug Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America GLP-1 Drug Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America GLP-1 Drug Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America GLP-1 Drug Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America GLP-1 Drug Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America GLP-1 Drug Sales Share by Country (2018-2029)
Figure 77. Brazil GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Israel GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries GLP-1 Drug Revenue (2018-2029) & (US$ Million)
Figure 82. GLP-1 Drug Value Chain
Figure 83. GLP-1 Drug Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries